ACCO Brands - Investor Relations - Investor Relations Home
OVERVIEW
IR.ACCOBRANDS.COM RANKINGS
Date Range
Date Range
Date Range
LINKS TO WEB PAGE
WHAT DOES IR.ACCOBRANDS.COM LOOK LIKE?
IR.ACCOBRANDS.COM HOST
PAGE TITLE
ACCO Brands - Investor Relations - Investor Relations HomeDESCRIPTION
Receive Materials by Email. Information About Mead Consumer and Office Products Merger. ACCO Brands Corporation NYSE ACCO is one of the worlds largest suppliers of select categories of branded school, office and consumer products and print finishing solutions, with revenues of 1.7 billion. We market products in over 100 countries across the globe through our own sales force and distribution networks. Our industry-leading brands and products include AT-A-GLANCE. 160; 0.32. Minimum 20 minute delay.CONTENT
This site has the following in the site, "Information About Mead Consumer and Office Products Merger." Our analyzers noticed that the web site also stated " ACCO Brands Corporation NYSE ACCO is one of the worlds largest suppliers of select categories of branded school, office and consumer products and print finishing solutions, with revenues of 1." The Website also stated " We market products in over 100 countries across the globe through our own sales force and distribution networks. Our industry-leading brands and products include AT-A-GLANCE."VIEW MORE BUSINESSES
Q2 2015 Accretive Health Inc Earnings Conference Call. Accretive Health is a leading provider of services and technology to healthcare providers. Our mission is to help our healthcare clients strengthen their financial stability and deliver better care at a more affordable cost to the communities they serve, increasing healthcare access for all. Our distinctive operating model that includes people, process, and sophisticated integrated technology helps our customers realize sus.
Q2 2015 AcelRx Pharmaceuticals, Inc. Q2 2015 AcelRx Pharmaceuticals, Inc. Click here to add this event to your calendar. AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results. Replication or redistribution of E.
Achillion to Present at the Barclays Global Healthcare Conference. Barclays Global Healthcare Conference 2018.
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
Our products are built on our elegant, field proven flywheel technology that delivers an unmatched combination of power density, reliability, and total cost of ownership. This combination enables our customers to achieve their availability, reliability, and budget goals. Q2 2015 Active Power, Inc. Active Power to Present at 43rd An.